This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Stephane Becart
Introduction
Stephane Becart is a notable inventor based in Cardiff by the Sea, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of antigen presentation.
Latest Patents
Stephane Becart holds a patent for "Inhibitors of antigen presentation by HLA-DR - Chromanone compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the inhibition of antigen presentation by HLA-DR." This patent highlights his innovative approach to addressing complex medical conditions.
Career Highlights
Becart is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work focuses on developing new therapeutic methods that can significantly impact patient care and treatment outcomes.
Collaborations
He has collaborated with notable colleagues such as Gavin C. Hirst and Kevin Douglas Kreutter, contributing to a dynamic research environment that fosters innovation.
Conclusion
Stephane Becart's work exemplifies the spirit of innovation in the pharmaceutical field, showcasing how targeted research can lead to advancements in medical treatments. His contributions are vital in the ongoing quest to improve health outcomes for patients.